| |
TNS Healthcare Unveils Oncology Market Tracker
In the US, TNS Healthcare has introduced a multi-country oncology market tracker that provides an in-depth look at any indication or patient segment.
The firm says its new OMT Focus uses a methodology that generates precise, national-level projections, validated against actual sales data. This enables clients to gain insights into even the smallest markets or patient populations, to measure and monitor share and prescribing changes, quantify opportunities, and manage and position their brands.
Multi-country coverage provides a view of a company's own and competitive performance, in any market it selects, across the US, Asia-Pacific and key European countries, including France, Germany, Italy, Spain and the UK.
'OMT Focus allows companies to 'zoom in' on the exact markets that are important to them for a complete look at segments, indications and treatment regimens,' said Michel Murino, MD of TNS Healthcare in France, and TNS Oncology Leader. 'The service delivers a full view of both treated and untreated patients for the most powerful and actionable analyses - right down to the most specific sub-segment.'
The new tracker is the latest offering in TNS Healthcare's Oncology 360o portfolio of oncology-specific solutions, designed to help companies with challenges unique to the oncology market.
TNS Healthcare provides both qualitative and quantitative offerings, using traditional and on-line methodologies, and employs around 200 healthcare research and consulting experts in over 80 countries.
Web site: www.tns-global.com .
Earlier in the year, Synovate Healthcare acquired US research firm Oncology, which provides oncology treatment information to pharmaceutical, biotech and financial companies.
|
